STOCK TITAN

John Marshall Financials

JMSB
Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE December

This page shows John Marshall (JMSB) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI JMSB FY2025

Margin recovery on a large asset base, not rapid balance-sheet expansion, is driving John Marshall Bancorp's earnings rebound.

With assets essentially flat across FY2023 through FY2025, net income rebounded from $5.2M to $21.2M. Because revenue rose only modestly over the same span, the recovery looks like spread and funding normalization on a largely unchanged balance sheet, which is why ROA and ROE improved to 0.9% and 8.0% in FY2025.

FY2025 operating cash flow of $22.6M sat close to net income of $21.2M, so reported profit is broadly turning into cash rather than being driven mainly by timing effects. Because annual capital spending was only $554K, free cash flow stayed close to operating cash flow, showing an asset-light overhead base outside the earning-asset book.

Equity rose from $229.9M in FY2023 to $265.6M in FY2025 even after dividends and buybacks, so the bank is rebuilding capital through retained earnings instead of relying on external funding. Meanwhile debt-to-equity eased to 30.5% from 32.8% in FY2024, which suggests the latest profit improvement strengthened the capital cushion faster than borrowings expanded.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Earnings Growth Capital Efficiency Credit Quality Stability 57 / 100
Financial Health Score 57/100
Scored as: Banks peer group

Scored against banks for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of John Marshall's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Earnings
32
Growth
89
Capital
53
Efficiency
57
Credit Quality
83
Stability
29
Piotroski F-Score Partial
5/6

John Marshall passes 5 of 6 computable financial strength tests (3 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 1 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed
1.06x

For every $1 of reported earnings, John Marshall generates $1.06 in operating cash flow ($22.6M OCF vs $21.2M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$113.3M
YoY+2.8%

John Marshall generated $113.3M in revenue in fiscal year 2025. This represents an increase of 2.8% from the prior year.

EBITDA
N/A
Net Income
$21.2M
YoY+24.0%

John Marshall reported $21.2M in net income in fiscal year 2025. This represents an increase of 24.0% from the prior year.

EPS (Diluted)
$1.49
YoY+24.2%

John Marshall earned $1.49 per diluted share (EPS) in fiscal year 2025. This represents an increase of 24.2% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$22.0M
YoY+31.3%

John Marshall generated $22.0M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 31.3% from the prior year.

Cash & Debt
$130.0M
YoY+6.1%

John Marshall held $130.0M in cash against $80.9M in long-term debt as of fiscal year 2025.

Dividends Per Share
$0.30
YoY+20.0%

John Marshall paid $0.30 per share in dividends in fiscal year 2025. This represents an increase of 20.0% from the prior year.

Shares Outstanding
N/A

Margins & Returns

Gross Margin
N/A
Operating Margin
N/A
Net Margin
18.8%
YoY+3.2pp

John Marshall's net profit margin was 18.8% in fiscal year 2025, showing the share of revenue converted to profit. This is up 3.2 percentage points from the prior year.

Return on Equity
8.0%
YoY+1.0pp

John Marshall's ROE was 8.0% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 1.0 percentage points from the prior year.

Capital Allocation

R&D Spending
N/A
Share Buybacks
$2.4M
YoY+4836.7%

John Marshall spent $2.4M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 4836.7% from the prior year.

Capital Expenditures
$554K
YoY+14.7%

John Marshall invested $554K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 14.7% from the prior year.

JMSB Income Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Revenue $29.1M-0.3% $29.2M+0.8% $28.9M+4.0% $27.8M+2.0% $27.3M-2.5% $28.0M-1.5% $28.4M+6.1% $26.8M
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $5.6M+18.1% $4.8M-16.4% $5.7M+9.9% $5.2M+1.5% $5.1M+9.5% $4.7M-4.9% $4.9M+0.5% $4.9M
Operating Income N/A N/A N/A N/A N/A N/A N/A N/A
Interest Expense $12.6M-4.9% $13.2M-0.9% $13.3M+3.3% $12.9M-2.2% $13.2M-5.2% $13.9M-8.8% $15.3M+3.8% $14.7M
Income Tax $1.7M-5.0% $1.8M+25.9% $1.5M-1.4% $1.5M+7.7% $1.4M+3.5% $1.3M+19.9% $1.1M-0.6% $1.1M
Net Income $6.1M+3.1% $5.9M+9.5% $5.4M+5.9% $5.1M+6.1% $4.8M+0.7% $4.8M+12.8% $4.2M+8.5% $3.9M
EPS (Diluted) $0.43 N/A $0.38+5.6% $0.36+5.9% $0.34 N/A $0.30+11.1% $0.27

JMSB Balance Sheet

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Total Assets $2.4B+0.8% $2.3B+0.3% $2.3B+2.5% $2.3B-0.2% $2.3B+1.7% $2.2B-1.7% $2.3B+0.2% $2.3B
Current Assets N/A N/A N/A N/A N/A N/A N/A N/A
Cash & Equivalents $150.2M+15.6% $130.0M-20.6% $163.6M+40.0% $116.9M-30.8% $169.1M+38.0% $122.5M-30.9% $177.2M-2.9% $182.6M
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities $2.1B+0.8% $2.1B+0.1% $2.1B+2.5% $2.0B-0.3% $2.0B+1.6% $2.0B-2.1% $2.0B-0.2% $2.0B
Current Liabilities N/A N/A N/A N/A N/A N/A N/A N/A
Long-Term Debt $80.9M0.0% $80.9M0.0% $80.9M0.0% $80.8M0.0% $80.8M0.0% $80.8M0.0% $80.8M+226.4% $24.7M
Total Equity $268.1M+0.9% $265.6M+2.3% $259.7M+2.3% $253.7M+0.3% $253.0M+2.6% $246.6M+1.4% $243.1M+3.3% $235.3M
Retained Earnings $181.7M+2.7% $176.9M+3.5% $171.0M+3.3% $165.6M+0.5% $164.8M+3.0% $160.0M+3.1% $155.2M+2.8% $150.9M

JMSB Cash Flow Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Operating Cash Flow $8.5M+23.8% $6.9M+464.8% $1.2M-83.8% $7.5M+8.3% $7.0M+26.6% $5.5M+288.3% $1.4M-86.1% $10.2M
Capital Expenditures $1K-94.4% $18K-45.5% $33K-79.5% $161K-52.9% $342K+35.7% $252K+137.7% $106K+112.0% $50K
Free Cash Flow $8.5M+24.2% $6.9M+479.1% $1.2M-83.9% $7.4M+11.4% $6.6M+26.1% $5.2M+300.5% $1.3M-87.1% $10.1M
Investing Cash Flow -$414K+99.0% -$43.2M-348.4% -$9.6M+78.9% -$45.7M-563.5% $9.9M+159.6% -$16.5M-80.2% -$9.2M-184.0% $10.9M
Financing Cash Flow $12.1M+353.3% $2.7M-95.2% $55.1M+493.9% -$14.0M-147.0% $29.8M+168.1% -$43.7M-1941.6% $2.4M-72.1% $8.5M
Dividends Paid $1.3M+127700.0% $1K $0 N/A N/A $0-100.0% $3K N/A
Share Buybacks $2.0M+166.0% $768K+161.2% $294K-77.6% $1.3M+2750.0% $46K $0+100.0% -$1K N/A

JMSB Financial Ratios

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin N/A N/A N/A N/A N/A N/A N/A N/A
Net Margin 21.0%+0.7pp 20.3%+1.6pp 18.7%+0.3pp 18.3%+0.7pp 17.6%+0.6pp 17.1%+2.2pp 14.9%+0.3pp 14.6%
Return on Equity 2.3%+0.1pp 2.2%+0.2pp 2.1%+0.1pp 2.0%+0.1pp 1.9%-0.0pp 1.9%+0.2pp 1.7%+0.1pp 1.7%
Return on Assets 0.3%0.0pp 0.3%+0.0pp 0.2%0.0pp 0.2%+0.0pp 0.2%0.0pp 0.2%+0.0pp 0.2%+0.0pp 0.2%
Current Ratio N/A N/A N/A N/A N/A N/A N/A N/A
Debt-to-Equity 0.300.0 0.300.0 0.310.0 0.320.0 0.320.0 0.330.0 0.33+0.2 0.11
FCF Margin 29.3%+5.8pp 23.5%+19.4pp 4.1%-22.4pp 26.5%+2.2pp 24.2%+5.5pp 18.7%+14.1pp 4.6%-33.2pp 37.8%

Similar Companies

Frequently Asked Questions

John Marshall (JMSB) reported $113.3M in total revenue for fiscal year 2025. This represents a 2.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

John Marshall (JMSB) revenue grew by 2.8% year-over-year, from $110.1M to $113.3M in fiscal year 2025.

Yes, John Marshall (JMSB) reported a net income of $21.2M in fiscal year 2025, with a net profit margin of 18.8%.

John Marshall (JMSB) reported diluted earnings per share of $1.49 for fiscal year 2025. This represents a 24.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

As of fiscal year 2025, John Marshall (JMSB) had $130.0M in cash and equivalents against $80.9M in long-term debt.

John Marshall (JMSB) had a net profit margin of 18.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, John Marshall (JMSB) paid $0.30 per share in dividends during fiscal year 2025.

John Marshall (JMSB) has a return on equity of 8.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

John Marshall (JMSB) generated $22.0M in free cash flow during fiscal year 2025. This represents a 31.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

John Marshall (JMSB) generated $22.6M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

John Marshall (JMSB) had $2.3B in total assets as of fiscal year 2025, including both current and long-term assets.

John Marshall (JMSB) invested $554K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Yes, John Marshall (JMSB) spent $2.4M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

John Marshall (JMSB) had a debt-to-equity ratio of 0.30 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

John Marshall (JMSB) had a return on assets of 0.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

John Marshall (JMSB) has a Piotroski F-Score of 5 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

John Marshall (JMSB) has an earnings quality ratio of 1.06x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

John Marshall (JMSB) scores 57 out of 100 on our Financial Health Score, indicating moderate standing within its banks peer group. The score is a 0-100 composite of six dimensions (Earnings, Growth, Capital, Efficiency, Credit Quality, Stability), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top